pralidoxime chloride 222 MG/ML
- RxCUI
- 1663723
- RxNorm name
- pralidoxime chloride 222 MG/ML
- Term type
- SCDC
- Status
- Active
- Updated
- 2026-10-21 00:27:56
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092015
- Active start
- 092015
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| 222 MG / 1 ML | pralidoxime |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| pralidoxime | 34345 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | pralidoxime chloride 222 MG/ML | 1 | NAMES |
| RxNorm Name | pralidoxime chloride 222 MG/ML | 1 | NAMES |
| TTY | SCDC | 1 | ATTRIBUTES |
| RxCUI | 1663723 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | V03AB | Antidotes | ATC1-4 | pralidoxime | |
| ATC | V03AB | Antidotes | ATC1-4 | atropine / pralidoxime | |
| FDASPL | N0000175742 | Cholinesterase Reactivator | EPC | has_epc | pralidoxime |
| FDASPL | N0000000080 | Cholinesterase Reactivators | MOA | has_moa | pralidoxime |
| MEDRT | D011220 | Pralidoxime Compounds | CHEM | has_ingredient | pralidoxime |
| MEDRT | D011220 | Pralidoxime Compounds | CHEM | has_ingredient | pralidoxime chloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | pralidoxime |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | pralidoxime chloride |
| MEDRT | D062787 | Drug Overdose | DISEASE | may_treat | pralidoxime |
| MEDRT | D062787 | Drug Overdose | DISEASE | may_treat | pralidoxime chloride |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | pralidoxime chloride |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_prevent | pralidoxime |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | pralidoxime |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_prevent | pralidoxime chloride |
| MEDRT | D011041 | Poisoning | DISEASE | ci_with | pralidoxime |
| MEDRT | D011041 | Poisoning | DISEASE | may_treat | pralidoxime chloride |
| MEDRT | D011041 | Poisoning | DISEASE | ci_with | pralidoxime chloride |
| MEDRT | D011041 | Poisoning | DISEASE | may_treat | pralidoxime |
| MEDRT | N0000000080 | Cholinesterase Reactivators | MOA | has_moa | pralidoxime |
| MEDRT | N0000000080 | Cholinesterase Reactivators | MOA | has_moa | pralidoxime chloride |
| MEDRT | N0000008383 | Decreased Acetylcholine Activity | PE | has_pe | pralidoxime |
| MEDRT | N0000008383 | Decreased Acetylcholine Activity | PE | has_pe | pralidoxime chloride |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | HYBRID |
| ATTRIBUTES | IN_EXPRESSED_FLAG | P |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | STRENGTH | 222 MG/ML |